Cargando…
Cardiovascular-related deaths at the beginning of the COVID-19 outbreak: a prospective analysis based on the UK Biobank
OBJECTIVE: To assess the impact of the COVID-19 outbreak on cardiovascular disease (CVD) related mortality and hospitalisation. DESIGN: Community-based prospective cohort study. SETTING: The UK Biobank. PARTICIPANTS: 421 372 UK Biobank participants who were registered in England and alive as of 1 Ja...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8184350/ https://www.ncbi.nlm.nih.gov/pubmed/34088708 http://dx.doi.org/10.1136/bmjopen-2020-046931 |
_version_ | 1783704575682805760 |
---|---|
author | Wang, Junren Zhu, Jianwei Yang, Huazhen Hu, Yao Sun, Yajing Ying, Zhiye Qu, Yuanyuan Valdimarsdottir, Unnur Fang, Fang Song, Huan |
author_facet | Wang, Junren Zhu, Jianwei Yang, Huazhen Hu, Yao Sun, Yajing Ying, Zhiye Qu, Yuanyuan Valdimarsdottir, Unnur Fang, Fang Song, Huan |
author_sort | Wang, Junren |
collection | PubMed |
description | OBJECTIVE: To assess the impact of the COVID-19 outbreak on cardiovascular disease (CVD) related mortality and hospitalisation. DESIGN: Community-based prospective cohort study. SETTING: The UK Biobank. PARTICIPANTS: 421 372 UK Biobank participants who were registered in England and alive as of 1 January 2020. PRIMARY AND SECONDARY OUTCOME MEASURES: The primary outcome of interest was CVD-related death, which was defined as death with CVD as a cause in the death register. We retrieved information on hospitalisations with CVD as the primary diagnosis from the UK Biobank hospital inpatient data. The study period was 1 January 2020 to June 30 2020, and we used the same calendar period of the three preceding years as the reference period. In order to control for seasonal variations and ageing of the study population, standardised mortality/incidence ratios (SMRs/SIRs) with 95% CIs were used to estimate the relative risk of CVD outcomes during the study period, compared with the reference period. RESULTS: We observed a distinct increase in CVD-related deaths in March and April 2020, compared with the corresponding months of the three preceding years. The observed number of CVD-related deaths (n=218) was almost double in April, compared with the expected number (n=120) (SMR=1.82, 95% CI 1.58 to 2.07). In addition, we observed a significant decline in CVD-related hospitalisations from March onwards, with the lowest SIR observed in April (0.45, 95% CI 0.41 to 0.49). CONCLUSIONS: There was a distinct increase in the number of CVD-related deaths in the UK Biobank population at the beginning of the COVID-19 outbreak. The shortage of medical resources for hospital care and stress reactions to the pandemic might have partially contributed to the excess CVD-related mortality, underscoring the need of sufficient healthcare resources and improved instructions to the public about seeking healthcare in a timely way. |
format | Online Article Text |
id | pubmed-8184350 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-81843502021-06-09 Cardiovascular-related deaths at the beginning of the COVID-19 outbreak: a prospective analysis based on the UK Biobank Wang, Junren Zhu, Jianwei Yang, Huazhen Hu, Yao Sun, Yajing Ying, Zhiye Qu, Yuanyuan Valdimarsdottir, Unnur Fang, Fang Song, Huan BMJ Open Cardiovascular Medicine OBJECTIVE: To assess the impact of the COVID-19 outbreak on cardiovascular disease (CVD) related mortality and hospitalisation. DESIGN: Community-based prospective cohort study. SETTING: The UK Biobank. PARTICIPANTS: 421 372 UK Biobank participants who were registered in England and alive as of 1 January 2020. PRIMARY AND SECONDARY OUTCOME MEASURES: The primary outcome of interest was CVD-related death, which was defined as death with CVD as a cause in the death register. We retrieved information on hospitalisations with CVD as the primary diagnosis from the UK Biobank hospital inpatient data. The study period was 1 January 2020 to June 30 2020, and we used the same calendar period of the three preceding years as the reference period. In order to control for seasonal variations and ageing of the study population, standardised mortality/incidence ratios (SMRs/SIRs) with 95% CIs were used to estimate the relative risk of CVD outcomes during the study period, compared with the reference period. RESULTS: We observed a distinct increase in CVD-related deaths in March and April 2020, compared with the corresponding months of the three preceding years. The observed number of CVD-related deaths (n=218) was almost double in April, compared with the expected number (n=120) (SMR=1.82, 95% CI 1.58 to 2.07). In addition, we observed a significant decline in CVD-related hospitalisations from March onwards, with the lowest SIR observed in April (0.45, 95% CI 0.41 to 0.49). CONCLUSIONS: There was a distinct increase in the number of CVD-related deaths in the UK Biobank population at the beginning of the COVID-19 outbreak. The shortage of medical resources for hospital care and stress reactions to the pandemic might have partially contributed to the excess CVD-related mortality, underscoring the need of sufficient healthcare resources and improved instructions to the public about seeking healthcare in a timely way. BMJ Publishing Group 2021-06-04 /pmc/articles/PMC8184350/ /pubmed/34088708 http://dx.doi.org/10.1136/bmjopen-2020-046931 Text en © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Cardiovascular Medicine Wang, Junren Zhu, Jianwei Yang, Huazhen Hu, Yao Sun, Yajing Ying, Zhiye Qu, Yuanyuan Valdimarsdottir, Unnur Fang, Fang Song, Huan Cardiovascular-related deaths at the beginning of the COVID-19 outbreak: a prospective analysis based on the UK Biobank |
title | Cardiovascular-related deaths at the beginning of the COVID-19 outbreak: a prospective analysis based on the UK Biobank |
title_full | Cardiovascular-related deaths at the beginning of the COVID-19 outbreak: a prospective analysis based on the UK Biobank |
title_fullStr | Cardiovascular-related deaths at the beginning of the COVID-19 outbreak: a prospective analysis based on the UK Biobank |
title_full_unstemmed | Cardiovascular-related deaths at the beginning of the COVID-19 outbreak: a prospective analysis based on the UK Biobank |
title_short | Cardiovascular-related deaths at the beginning of the COVID-19 outbreak: a prospective analysis based on the UK Biobank |
title_sort | cardiovascular-related deaths at the beginning of the covid-19 outbreak: a prospective analysis based on the uk biobank |
topic | Cardiovascular Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8184350/ https://www.ncbi.nlm.nih.gov/pubmed/34088708 http://dx.doi.org/10.1136/bmjopen-2020-046931 |
work_keys_str_mv | AT wangjunren cardiovascularrelateddeathsatthebeginningofthecovid19outbreakaprospectiveanalysisbasedontheukbiobank AT zhujianwei cardiovascularrelateddeathsatthebeginningofthecovid19outbreakaprospectiveanalysisbasedontheukbiobank AT yanghuazhen cardiovascularrelateddeathsatthebeginningofthecovid19outbreakaprospectiveanalysisbasedontheukbiobank AT huyao cardiovascularrelateddeathsatthebeginningofthecovid19outbreakaprospectiveanalysisbasedontheukbiobank AT sunyajing cardiovascularrelateddeathsatthebeginningofthecovid19outbreakaprospectiveanalysisbasedontheukbiobank AT yingzhiye cardiovascularrelateddeathsatthebeginningofthecovid19outbreakaprospectiveanalysisbasedontheukbiobank AT quyuanyuan cardiovascularrelateddeathsatthebeginningofthecovid19outbreakaprospectiveanalysisbasedontheukbiobank AT valdimarsdottirunnur cardiovascularrelateddeathsatthebeginningofthecovid19outbreakaprospectiveanalysisbasedontheukbiobank AT fangfang cardiovascularrelateddeathsatthebeginningofthecovid19outbreakaprospectiveanalysisbasedontheukbiobank AT songhuan cardiovascularrelateddeathsatthebeginningofthecovid19outbreakaprospectiveanalysisbasedontheukbiobank |